Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 16

1.

Decision curve analysis: a discussion.

Steyerberg EW, Vickers AJ.

Med Decis Making. 2008 Jan-Feb;28(1):146-9. doi: 10.1177/0272989X07312725. No abstract available.

2.

Prostate cancer: Time for active surveillance of intermediate-risk disease?

Ahmed HU.

Nat Rev Urol. 2013 Jan;10(1):6-8. doi: 10.1038/nrurol.2012.213. Epub 2012 Nov 13. Review. No abstract available.

PMID:
23147924
3.

Promoting informed decision making about prostate cancer screening.

Chan EC.

Compr Ther. 2001 Fall;27(3):195-201. Review.

PMID:
11569319
4.

Screening for prostate cancer with prostate-specific antigen. An examination of the evidence.

Woolf SH.

N Engl J Med. 1995 Nov 23;333(21):1401-5. Review. No abstract available.

PMID:
7477122
5.

American Urological Association (AUA) guideline on prostate cancer detection: process and rationale.

Carter HB.

BJU Int. 2013 Sep;112(5):543-7. doi: 10.1111/bju.12318. Review.

6.

Health decision aids to facilitate shared decision making in office practice.

Barry MJ.

Ann Intern Med. 2002 Jan 15;136(2):127-35. Review.

PMID:
11790064
7.

Clinical practice. Screening for prostate cancer.

Hoffman RM.

N Engl J Med. 2011 Nov 24;365(21):2013-9. doi: 10.1056/NEJMcp1103642. Epub 2011 Oct 26. Review. No abstract available.

8.

Prostate-specific antigen in the early detection of prostate cancer.

Thompson IM, Ankerst DP.

CMAJ. 2007 Jun 19;176(13):1853-8. Review.

9.
10.

Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline.

Loblaw DA, Virgo KS, Nam R, Somerfield MR, Ben-Josef E, Mendelson DS, Middleton R, Sharp SA, Smith TJ, Talcott J, Taplin M, Vogelzang NJ, Wade JL 3rd, Bennett CL, Scher HI; American Society of Clinical Oncology.

J Clin Oncol. 2007 Apr 20;25(12):1596-605. Epub 2007 Apr 2. Review.

PMID:
17404365
11.

Management of early prostate cancer.

Horwich A, Parker CC, Huddart RA, Dearnaley DP.

Ann Oncol. 2002;13 Suppl 4:83-7. Review. No abstract available.

12.

Early detection of prostate cancer: European Association of Urology recommendation.

Heidenreich A, Abrahamsson PA, Artibani W, Catto J, Montorsi F, Van Poppel H, Wirth M, Mottet N; European Association of Urology.

Eur Urol. 2013 Sep;64(3):347-54. doi: 10.1016/j.eururo.2013.06.051. Epub 2013 Jul 9. Review.

PMID:
23856038
13.

American Cancer Society guideline for the early detection of prostate cancer: update 2010.

Wolf AM, Wender RC, Etzioni RB, Thompson IM, D'Amico AV, Volk RJ, Brooks DD, Dash C, Guessous I, Andrews K, DeSantis C, Smith RA; American Cancer Society Prostate Cancer Advisory Committee.

CA Cancer J Clin. 2010 Mar-Apr;60(2):70-98. doi: 10.3322/caac.20066. Epub 2010 Mar 3. Review.

14.

Prostate-specific antigen.

Brawer MK.

Semin Surg Oncol. 2000 Jan-Feb;18(1):3-9. Review.

PMID:
10617891
15.

What to do with an abnormal PSA test.

Loeb S, Catalona WJ.

Oncologist. 2008 Mar;13(3):299-305. doi: 10.1634/theoncologist.2007-0139. Review.

16.

Prostate cancer screening.

Cook ED, Nelson AC.

Curr Oncol Rep. 2011 Feb;13(1):57-62. doi: 10.1007/s11912-010-0136-x. Review.

PMID:
20981510
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk